SG

StoneX Group Portfolio holdings

AUM $2.3B
1-Year Est. Return 19.48%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+19.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.29B
AUM Growth
+$237M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,081
New
Increased
Reduced
Closed

Top Buys

1 +$20.8M
2 +$19.8M
3 +$8.05M
4
ORLA
Orla Mining
ORLA
+$7.29M
5
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$6.61M

Sector Composition

1 Technology 9.89%
2 Financials 4.89%
3 Communication Services 3.52%
4 Consumer Discretionary 3.25%
5 Industrials 2.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KR icon
1001
Kroger
KR
$46.4B
-3,543
LDP icon
1002
Cohen & Steers Duration Preferred & Income Fund
LDP
$596M
-11,720
MAG
1003
DELISTED
MAG Silver
MAG
-24,627
MFIC icon
1004
MidCap Financial Investment
MFIC
$962M
-13,956
MNSB icon
1005
MainStreet Bancshares
MNSB
$165M
-23,940
MSOX icon
1006
AdvisorShares MSOS 2X Daily ETF
MSOX
$37.6M
-13,644
NHS
1007
Neuberger High Yield Strategies Fund Inc
NHS
$235M
-39,085
NVAX icon
1008
Novavax
NVAX
$1.72B
-47,126
NVD icon
1009
GraniteShares 2x Short NVDA Daily ETF
NVD
$33.9M
-15,879
NVDL icon
1010
GraniteShares ETF Trust GraniteShares 2x Long NVDA Daily ETF
NVDL
$3.94B
-11,574
NVDS icon
1011
Tradr 1.25X NVDA Bear Daily ETF
NVDS
$134M
-5,273
NVR icon
1012
NVR
NVR
$19.2B
-55
NXTG icon
1013
First Trust Indxx NextG ETF
NXTG
$434M
-2,414
OAIM icon
1014
OneAscent International Equity ETF
OAIM
$278M
-31,733
OLO
1015
DELISTED
Olo Inc
OLO
-101,056
OSCR icon
1016
Oscar Health
OSCR
$4.16B
-11,850
PECO icon
1017
Phillips Edison & Co
PECO
$4.86B
-6,786
PFN
1018
PIMCO Income Strategy Fund II
PFN
$659M
-14,685
PGR icon
1019
Progressive
PGR
$121B
-862
PKST
1020
Peakstone Realty Trust
PKST
$773M
-15,118
PTY icon
1021
PIMCO Corporate & Income Opportunity Fund
PTY
$2.35B
-10,241
QLD icon
1022
ProShares Ultra QQQ
QLD
$9.85B
-5,310
RCL icon
1023
Royal Caribbean
RCL
$78.6B
-691
RCS
1024
PIMCO Strategic Income Fund
RCS
$262M
-10,308
REVB icon
1025
Revelation Biosciences
REVB
$3.36M
-851